Long COVID: Have US scientists found a cure? Jie Sun UVA School of Medicine UVA ID ow.ly/Wf5o50VeLI5

CIC member Jie Sun is featured in this article!

WTRF: 'Scientist find how severe COVID-19 can destroy immune cells’ ability to repair the lungs, New treatment approach for COVID' The UVA team found that sodium phenylbutyrate, a drug already approved by the FDA, may help repair these damaged peroxisomes wtrf.com/news/national-…

CBS 19 News: 'Researchers learning more about impacts of severe respiratory infections' 'The scientists say this helps to explain the lingering impacts of long COVID, with these findings suggesting a new treatment approach for long COVID' cbs19news.com/news/researche…

A new Science study in mice reports dysfunction in alveolar macrophages as a contributing factor to persistent lung pathology after #SARSCoV2 infection. The findings suggest avenues for therapeutic intervention. 📄: scim.ag/4kJaHo7 #SciencePerspective:

COVID long et inflammation post-infection #SARSCoV2 via les macrophages alvéolaires (cellules immunitaires dans les alvéoles des poumons) : une piste thérapeutique très intéressante qui pourrait limiter les complications et séquelles post-infection virale #covidlong 👏Xiaoqin Wei

“In human patients with post-acute sequelae, or long COVID, researchers identified a parallel phenotype of chronic peroxisome impairment as seen in mice.” genengnews.com/topics/coronav…

Two of our researchers made it to Round 2 of #STATMadness2025! 🏆 Help Jie Sun of UVA School of Medicine and #UVAHealth Children's take the title of 2024's best biomedical research by following these 3 easy steps. 🗳️ Vote here: bit.ly/4iyRX90

Macrophages Fight COVID-19-Induced Lung Damage with Peroxisomes Research at UVA School of Medicine identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing U.S. FDA approved drug. Jie Sun hubs.li/Q03bTSYd0

Join us!🌟🌟

Researchers find that severe COVID-19 can disrupt peroxisomes in macrophages, an immune cell type specialized in engulfing cellular debris and pathogens. This disruption led to impaired lung repair, prolonged inflammation, and chronic fibrosis. 1/

Extracellular vesicles transport gasdermin pores, amplifying inflammatory cell death dlvr.it/TJcFyZ

Severe respiratory viral infections impair peroxisomes in macrophages, worsening lung inflammation and tissue damage post-COVID-19. Boosting peroxisome function may be a promising therapy for reducing complications of viral respiratory infections. buff.ly/YZMlEZW

Congratulations!!! Anne Sperling, PhD, ATSF #ATS2025

The #SIS2025 swag bags are ready -- are you? We're looking forward to hosting the Southeastern Immunology Symposium UVA in 3 days!

We are hiring! Please help spread the words. Thank you! nature.com/naturecareers/…

Excited to share our new work: Respiratory viral infections like COVID-19 and flu prime enhanced lung cancer development. Our study establishes a direct causal link, highlighting the urgent need for long-term cancer surveillance in COVID-19 survivors.  doi.org/10.1101/2025.0…

So grateful that my lab is celebrating its 25th anniversary next week! Super lucky to work with such an inspiring team that made this possible 🙏🏼🙏🏼🙏🏼 Join us as we celebrate our 25th anniversary with a special symposium 🤗 Yale School of Medicine